GlassScriptPhysician profile
Alexander Patrick Mcnally
NPI 1003401464
$4,111.09
in general payments reported to CMS, 2019-2025
17 companies · $3,628 in 2025
The $3,628 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $72.00 · 2023: $238 · 2024: $173 · 2025: $3,628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,761 · Food and Beverage: $1,278 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,760.82 |
| Food and Beverage | $1,278.27 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,041.98 | 2025 | |
| Aroa Biosurgery Incorporated | $254.89 | 2024-2025 | |
| Davol INC. | $155.53 | 2023 | Phasix Mesh |
| Avita Medical Americas, LLC | $152.71 | 2025 | Cohealyx, Permeaderm, Recell |
| Polynovo North America LLC | $143.18 | 2025 | Novosorb Btm |
| Tela Bio, INC. | $64.21 | 2024 | Ovitex 2s |
| Incyte Corporation | $43.13 | 2022-2024 | Jakafi |
| Boston Scientific Corporation | $40.79 | 2025 | Spyglass Discover |
| Baxter Healthcare | $36.38 | 2023 | Tisseel |
| Currax Pharmaceuticals LLC | $30.26 | 2022-2024 | Contrave |
| Kci USA, INC. | $27.42 | 2023 | V.A.C.Ulta, Prevena, Abthera Advance |
| Medtronic, INC. | $26.80 | 2025 | Maxtack |
| Abiomed | $22.60 | 2025 | |
| Heron Therapeutics, INC. | $20.81 | 2024 | Zynrelef |
| Convatec INC. | $18.46 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $18.29 | 2023 | Fetroja |
| Merck Sharp & Dohme LLC | $13.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Mcnally listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.